Lymphocytic Choriomeningitis Virus Infection in FVB Mouse Produces Hemorrhagic Disease
Open Access
- 27 December 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 8 (12), e1003073
- https://doi.org/10.1371/journal.ppat.1003073
Abstract
The viral family Arenaviridae includes a number of viruses that can cause hemorrhagic fever in humans. Arenavirus infection often involves multiple organs and can lead to capillary instability, impaired hemostasis, and death. Preclinical testing for development of antiviral or therapeutics is in part hampered due to a lack of an immunologically well-defined rodent model that exhibits similar acute hemorrhagic illness or sequelae compared to the human disease. We have identified the FVB mouse strain, which succumbs to a hemorrhagic fever-like illness when infected with lymphocytic choriomeningitis virus (LCMV). FVB mice infected with LCMV demonstrate high mortality associated with thrombocytopenia, hepatocellular and splenic necrosis, and cutaneous hemorrhage. Investigation of inflammatory mediators revealed increased IFN-γ, IL-6 and IL-17, along with increased chemokine production, at early times after LCMV infection, which suggests that a viral-induced host immune response is the cause of the pathology. Depletion of T cells at time of infection prevented mortality in all treated animals. Antisense-targeted reduction of IL-17 cytokine responsiveness provided significant protection from hemorrhagic pathology. F1 mice derived from FVB×C57BL/6 mating exhibit disease signs and mortality concomitant with the FVB challenged mice, extending this model to more widely available immunological tools. This report offers a novel animal model for arenavirus research and pre-clinical therapeutic testing. Arenaviruses are carried by rodents, and in South America and West Africa can cause a fatal hemorrhagic fever syndrome in humans. Food, water or household items contaminated with rodent urine can be a source for transmission. General supportive care, anti-fever medication and the antiviral drug Ribaviran are used, however no treatment has proven effective. Due to the lack of small animal models capable of reproducing the human disease, development of an effective therapeutic has been slow. Here we report that a common laboratory arenavirus isolate, lymphocytic choriomeningitis virus, known to cause only a mild infection in humans and a chronic, wasting disease in most laboratory strains of mice produces a hemorrhagic-like disease in the FVB mouse strain. These mice exhibit signs of bleeding, multi–organ involvement, changes in blood diagnostics and mortality indicative of hemorrhagic fever syndrome following infection. We also show that a drug approach to reduce inflammation as a result of immune responses to the virus reduced disease signs and improved survival. Our study provides a small animal model for testing new treatment approaches and points to drug targets that lessen disease severity and improve survival from arenavirus induced hemorrhagic fever.Keywords
This publication has 31 references indexed in Scilit:
- IL-17 and TNF-α Sustain Neutrophil Recruitment during Inflammation through Synergistic Effects on Endothelial ActivationPublished by The American Association of Immunologists ,2012
- Development of Peptide-Conjugated Morpholino Oligomers as Pan-Arenavirus InhibitorsAntimicrobial Agents and Chemotherapy, 2011
- Development of a New Tacaribe Arenavirus Infection Model and Its Use to Explore Antiviral Activity of a Novel Aristeromycin AnalogPLOS ONE, 2010
- T‐cell exhaustion: characteristics, causes and conversionImmunology, 2010
- ArenavirusesPublished by Wiley ,2009
- Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation by a proteasome inhibitorPhysiological Genomics, 2009
- Anomalous Type 17 Response to Viral Infection by CD8 + T Cells Lacking T-bet and EomesoderminScience, 2008
- Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivoJournal of Virological Methods, 2008
- Platelets prevent IFN-α/β-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virusProceedings of the National Academy of Sciences of the United States of America, 2008
- Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice.The Journal of Experimental Medicine, 1990